Bifiform Plus 20 capsules - Gastrointestinal , bowel and liver disorders

Information about the drug, given in this section is intended for medical and pharmaceutical professionals and should not be used for self-treatment. Information given to familiarize with the basic properties of the drug and cannot be considered as official.

BIFIFORM

for medical use of the drug

The composition of the drug:

active substances:

bifidobacteria (Bifidobacterium longum) - 107 CFU (live organisms) ≈ 10 and 75 mg;

enterococci (Enterococcus faecium) - 107 CFU (live organisms) ≈ 17,2 mg;

excipients: glucose anhydrous, yeast, syrup, carob beans, lactulose, gelatin, methacrylate copolymer dispersion, methacry salary copolymer (type A), talc, magnesium stearate, poly ethylene glycol (macrogol 6000), soybean oil, mono glycerides acutiloba, titanium dioxide (E 171).

Dosage form. Capsules.

Capsules solid, acid-resistant, milk-white, with a neutral odour.

The name and address of manufacturer: Ferrosan A/s, Denmark/Ferrosan A/S, Denmark; Pharma Vinci A/s, Denmark/Pharma-Vinci A/S, Denmark.

Pharmacotherapeutic group. Antidiarrheal of microbial preparations. ATC code AND 07F.

The mechanism of action of lactic acid bacteria is their ability to restore natural gut flora. Some lactic acid bacteria can metabolize lactose, thus reducing the formation of gas in the intestines. It reduces flatulence in patients with lactose intolerance.

Indications for use.

Normalization of intestinal flora, diarrhea, antibiotic therapy, eating disorders. Can a person with lactose intolerance.

Contraindications. Not known.

Special warnings. If, despite treatment, the symptoms last more than two days, the stool has blood or diarrhea is accompanied by fever, consult a doctor.

Because the drug contains live micro-organisms that can be used in patients with reduced immune response is possible only on prescription, which will determine the ratio risk/benefit.

Use during pregnancy or breast-feeding. The drug can be used in recommended doses.

The ability to influence the rate of reaction at management of motor transport or operating other mechanisms. Not affected.

Children. Used in children aged 2 months. In order to avoid falling capsules in the respiratory tract in children aged from 2 months to 2 years, you need to open the capsule and mix contents with food.

Method of application and doses. Used internally. The capsule should be swallowed without chewing.

Adults and children over 2 years - 1 capsule 2 times a day, regardless of meals. The dose may be increased to 4 capsules per day (2 capsules 2 times a day).

Infants aged from 6 to 12 months: 1 capsule 2 times a day.

Infants aged 2 to 6 months: 1 capsule 1 time per day. In infants use in the first half of the day. In order to avoid falling capsules in the respiratory tract in children aged from 2 months to 2 years, you need to open the capsule and mix contents with food.

For the prevention of traveler's diarrhea and antibiotic-associated diarrhea: 1 capsule 2 times a day.

Overdose. It is not known.

Side effects. Not known.

Interaction with other medicinal products and other forms of interaction.

Lactic acid bacteria are sensitive to certain antibiotics. Therefore, while the holding of antibiotic therapy, it is advisable to take the drug Bifiform interval in hours between doses of antibiotics.

The expiration date. 24 months.

The storage conditions. Keep at temperature not exceeding 25 °C, inaccessible for children place. To prevent exposure to high temperatures and humidity.

Packing. Aluminum container containing 20 capsules, closed the lid with a desiccant, placed in a cardboard box.

 

Write a review

Your Name:


Your Review: Note: HTML is not translated!

Rating: Bad           Good

Enter the code in the box below: